3rd Quarter - Report
PARAGON BIOSCIENCES, LLC for PARAGON BIOSCIENCES, LLC
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
Science/Technology SCI
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.